ImmixBio Announces Dr. George W. Sledge of Stanford University Medical Center Joins Scientific Advisory Board

LOS ANGELES: LOS ANGELES, Aug. 9, 2021 /PRNewswire/ -- Immix Biopharma, Inc. ("ImmixBio"), a biotechnology company pioneering Tissue Specific Therapeutics (TSTx)TM for oncology and inflammation, today announced that George W. Sledge, MD, Professor of Medical Oncology and former Chief of Medical Oncology at Stanford University Medical Center has joined its...

Click to view original post